Ruo-Jing Li

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Replacement Therapy

Acute Lymphoblastic Leukemia

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Ashley C Woods, Kelly J Norsworthy, Xin Wang, Jonathon Vallejo, Edwin C Y Chow, Ruo-Jing Li, Jielin Sun, Rosane Charlab, Xiling Jiang, Richard Pazdur, Marc R Theoret, R Angelo de Claro
FDA Approval Summary: Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Donna Przepiorka, Robert Q Le, Alexei Ionan, Ruo-Jing Li, Ying-Hong Wang, Ramadevi Gudi, Soumya Mitra, Jonathon Vallejo, Olanrewaju O Okusanya, Lian Ma, Yuching Yang, Paresma Patel, Djelila Mezaache, Rakhi Shah, Anamitro Banerjee, Sherita McLamore, Adam N Maung, Kirsten B Goldberg, Richard Pazdur, Marc R Theoret, R Angelo De Claro
FDA Approval Summary: Belumosudil for Adult and Pediatric Patients 12 Years and Older with Chronic GvHD after Two or More Prior Lines of Systemic Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (12) (2022)
Ruo-Jing Li, Runyan Jin, Chao Liu, Xianhua Cao, Michael L Manning, Xu Michael Di, Donna Przepiorka, Frances Namuswe, Albert Deisseroth, Kirsten B Goldberg, Gideon M Blumenthal, Richard Pazdur
FDA Approval Summary: Calaspargase Pegol-mknl For Treatment of Acute Lymphoblastic Leukemia in Children and Young Adults. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (2) (2019)